학술논문

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR - or ALK -Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 10 April 2024, 42(11):1241-1251)
Subject
Language
English
ISSN
15277755
0732183X